000 | 01015 a2200313 4500 | ||
---|---|---|---|
005 | 20250513020159.0 | ||
264 | 0 | _c19811221 | |
008 | 198112s 0 0 eng d | ||
022 | _a0160-564X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJörstad, S | |
245 | 0 | 0 |
_aToxicity of middle molecules: clinical evaluation using a selective filtration artificial kidney. _h[electronic resource] |
260 |
_bArtificial organs _c1981 |
||
300 |
_a98-103 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCreatinine _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKidneys, Artificial |
650 | 0 | 4 |
_aPhagocytes _xdrug effects |
650 | 0 | 4 | _aRenal Dialysis |
650 | 0 | 4 |
_aToxins, Biological _xblood |
650 | 0 | 4 |
_aUrea _xmetabolism |
650 | 0 | 4 |
_aUremia _xtherapy |
700 | 1 | _aSmeby, L C | |
700 | 1 | _aWideröe, T E | |
773 | 0 |
_tArtificial organs _gvol. 4 Suppl _gp. 98-103 |
|
999 |
_c7294616 _d7294616 |